High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...

Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments ...

Investorideas.com ( a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the ...

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with ...